PPD01.01 ctDNA Dynamics, Prognostic Markers and Resistance Mechanisms in Tepotinib-treated MET exon 14 (METex14) Skipping NSCLC in the VISION TrialXiuning Le, Paul K. Paik, Myung‐Ju Ahn et al.|Journal of Thoracic Oncology|2024Cited by 0